key: cord-0842437-famjqhd3
authors: Waltz, Margaret; Bensen, Jeannette; Foreman, Ann Katherine M.; Grant, Tracey; Lich, Kristen Hassmiller; Mollison, Lonna; Staley, Brooke; Cadigan, R. Jean
title: eP466 The impact of COVID-19 on pediatric diagnostic odysseys
date: 2021-04-30
journal: Molecular Genetics and Metabolism
DOI: 10.1016/s1096-7192(21)00545-x
sha: 54b13fb9fe06e1e81b54b5f49d081ff8f3ff18b4
doc_id: 842437
cord_uid: famjqhd3

For those with undiagnosed conditions, the “diagnostic odyssey” can be long, expensive, and marked by uncertainty as patients and their families search for a diagnosis. The North Carolina Clinical Genomic Evaluation by Next-Generation Exome Sequencing 2 (NCGENES 2) study aims to shorten the diagnostic odyssey of children with suspected genetic conditions by comparing outcomes of patients who undergo diagnostic exome sequencing at an early point in the diagnostic process to outcomes of patients who undergo usual care. Given that recruitment started in August of 2018, was temporarily suspended due to COVID-19, and is currently ongoing, we sought to understand whether and how participants’ diagnostic odysseys have been impacted by COVID-19. Therefore,we interviewed 25 NCGENES 2 parent participants about howCOVID-19 has impacted their daily lives as well as their child’s medical care and diagnostic odyssey. Analysis is ongoing, but preliminary findings indicate that parents perceived a range of burdens due to the COVID-19 pandemic. These burdens include having to deal with isolation due to social distancing, becoming surrogate teachers through online schooling, and, for some, actually getting COVID-19. When asked about interruptions to their child’s medical appointments and care, participants did not describe delays in the diagnostic odysseys as many doctor’s appointmentswere not interrupted due to COVID-19. However, almost all parents discussed the difficulties of getting needed in-person therapies, like speech, occupational, or physical, for their children either because therapists were no longer offering in person meetings or because parents were not comfortable meeting in person. Some parents also noted difficulties in conducting virtual therapy: having to hold phones while also helping their children and how their children “don’t perform as well for mom” as they do for the therapists. Because of the lack of or delays in therapies, many parents said that their children were “not making progress.” In addition to these burdens, some parents identified benefits of the COVID-19 pandemic, including that social distancing caused fewer colds or other illnesses to pass through their households. Others discussed feeling lucky that they have not been impacted financially during this time. Overall, we found that NCGENES 2 participants’ daily lives have been greatly impacted by COVID-19 because of social distancing and online schooling. However, these findings also indicate that it is not the diagnostic odyssey that was interrupted by the COVID-19 pandemic but the therapeutic odyssey. We conclude with a discussion of the importance of focusing on the therapeutic odyssey in both research and clinical practice.

testing in a science-educated young adult community, as a result of taking a Personalized Medicine course. The goal of the course was to educate students on the uses, limitations, and potential risks associated with DTC genetic testing. The course also sought to educate future health care professionals on the use of genetic testing in the health care setting through problem-based learning activities. Missouri State University Honors Students enrolled in the UHC 397: Personalized Medicine course over two semesters consented to participation in an ongoing study that involved pre-, mid-, and postcourse surveys. Twenty students have completed the pre-course survey and 11 completed the post-course survey. All of the students had previously taken a general genetics course, and 15% had taken an advanced genetics course. None had participated in clinical genetic testing prior to the course and 10% had participated in DTC genetic testing. Following the course, we saw a 10% increase in student responses that agreed or strongly agreed that DTC genetic testing is useful to patients. Further, the post-test identified that 90% of respondents agree or strongly agree that it is important for a physician and/or genetic counselor to help patients interpret DTC genetic testing data. In addition, following the course, we saw a 3-fold increase in respondents that felt DTC genetic testing was trustworthy. These data, taken together, suggest that both attitudes and understanding of DTC genetic testing can be influenced through education. Introduction: The coronavirus pandemic has reset major work trends, making remote teams and working from home the new normal. As workplaces continue to hire, the ability to remotely onboard and train new employees has become essential. Here, we describe Natera's clinical laboratory experience in creating and implementing a variant curator training plan that integrates shadowing, case-based and simulation-based learning adapted to an individual's learning preferences. Additionally, it introduces core ACMG/AMP interpretation guidelines and classification concepts critical for curating variants in a carrier screening panel for requisite patient safety. Objective: To describe and explore the efficacy of a virtual training tool for new variant curation employees at Natera, Inc. Materials and Methods: The virtual variant curator training consists of a "MASTER" six-module curriculum and requires the same basic requirements needed for remote working, such as video conferencing capabilities, screen sharing, and document sharing. Results: In 2019, prior to implementing the fully remote MASTER modular training, 5 trainees were hired throughout the year and were trained individually by 2 primary trainers. The final week of training was completed in person and on-site at the San Carlos headquarters such that the complete training time from the first date of hire until completion took an average of 30.20 ± 7.56 days (range: 22-38). In 2020, fully remote virtual variant curator training was conducted with 9 trainees in cohorts of 5, 2, and 2. The data show an average training time of 19.22 ± 6.08 days (range: 14-30 days), which was significantly shorter than the previous year, p = 0.0115; Δ = 10.98; df = 12. The training time required by the first cohort (n = 5), trained by 2 trainers, was shorter at 15.60 ± 1.34 days, compared to the following 2 cohorts (n = 2 each), trained by 3 trainers, 23.75 ± 6.85 days. Of note, the first cohort joined during a period of increased novel variant volumes associated with increasing the panel size from 27 to 274 genes, and a need for new hires to complete training rapidly. Despite the difference in training time due to production demand, the overall curriculum is reinforced through the later module of continued learning. No significant difference in training time was observed between the 2020 trainees who had prior experience (n = 6, mean: 17.83 ± 6.05 days) with variant curation, compared to those with no prior experience (n = 3, mean:22.00 ± 6.24), p = 0.3665; Δ = 4.17; df = 7. For those with undiagnosed conditions, the "diagnostic odyssey" can be long, expensive, and marked by uncertainty as patients and their families search for a diagnosis. The North Carolina Clinical Genomic Evaluation by Next-Generation Exome Sequencing 2 (NCGENES 2) study aims to shorten the diagnostic odyssey of children with suspected genetic conditions by comparing outcomes of patients who undergo diagnostic exome sequencing at an early point in the diagnostic process to outcomes of patients who undergo usual care. Given that recruitment started in August of 2018, was temporarily suspended due to COVID-19, and is currently ongoing, we sought to understand whether and how participants' diagnostic odysseys have been impacted by COVID-19. Therefore, we interviewed 25 NCGENES 2 parent participants about how COVID-19 has impacted their daily lives as well as their child's medical care and diagnostic odyssey. Analysis is ongoing, but preliminary findings indicate that parents perceived a range of burdens due to the COVID-19 pandemic. These burdens include having to deal with isolation due to social distancing, becoming surrogate teachers through online schooling, and, for some, actually getting COVID-19. When asked about interruptions to their child's medical appointments and care, participants did not describe delays in the diagnostic odysseys as many doctor's appointments were not interrupted due to COVID-19. However, almost all parents discussed the difficulties of getting needed in-person therapies, like speech, occupational, or physical, for their children either because therapists were no longer offering in person meetings or because parents were not comfortable meeting in person. Some parents also noted difficulties in conducting virtual therapy: having to hold phones while also helping their children and how their children "don't perform as well for mom" as they do for the therapists. Because of the lack of or delays in therapies, many parents said that their children were "not making progress." In addition to these burdens, some parents identified benefits of the COVID-19 pandemic, including that social distancing caused fewer colds or other illnesses to pass through their households. Others discussed feeling lucky that they have not been impacted financially during this time. Overall, we found that NCGENES 2 participants' daily lives have been greatly impacted by COVID-19 because of social distancing and online schooling. However, these findings also indicate that it is not the diagnostic odyssey that was interrupted by the COVID-19 pandemic but the therapeutic odyssey. We conclude with a discussion of the importance of focusing on the therapeutic odyssey in both research and clinical practice. . In order to help them confidently practice genomic medicine, we sought to identify specific educational needs of non-geneticist clinicians at the University of California, San Francisco (UCSF). Methods: In a mixed methods study, we conducted semi-structured key informant interviews with 13 Department Chairs from UCSF School of Medicine. We identified themes using thematic qualitative analysis. These results informed development of a 28-item survey widely distributed to clinical departments. We excluded survey responses from individuals with genetics training.. Results: The following themes emerged from the interviews: genetics/genomics are underutilized in clinical practice, more education is needed for trainees and clinicians, and having clinicians with genetics expertise within departments is crucial to improving the utilization of genetics/genomics. There were 134 survey respondents with most from the Department of Medicine (29%), followed by Pediatrics (17%), Family and Community Medicine (8%), Anesthesia and Perioperative Care (8%), Dermatology (7%), and 13 other departments. Most (81%) reported they would be more comfortable using genetics/genomics in clinical practice with additional training and overwhelmingly prefer online (80%) to inperson format (33%). Lack of knowledge was cited as the primary reason for not ordering genetic tests (51%). Only 36% reported participating in genetics continuing medical education (CME); among those who had not participated, 61% cited lack of awareness of CME courses while 14% cited lack of need. The vast majority (90%) who do participate in CME indicated they would benefit from additional training.

To see if educational needs differed, respondents were stratified by frequency of ordering genetic tests and making genetics referrals into four groups: 1) frequently order tests and frequently refer (31%); 2) frequently order tests and infrequently refer (16%); 3) infrequently order tests and frequently refer (13%); 4) infrequently order and infrequently refer (41%). When asked about performing geneticsrelated clinical activities, respondents who frequently order tests expressed high confidence in their ability to communicate tests results to patients (60%), ask patients directed questions to investigate a potential underlying genetic diagnosis (60%), explain the difference between types of genetic variants (50%), and recognize indications for a referral (66%). Respondents who infrequently order tests and infrequently refer have low confidence across all activities, especially interpreting genetic test results (69%), explaining different types of genetic variants (67%), determining if follow-up testing is indicated (66%), and using test results to make clinical decisions (62%). Respondents in all four groups had low confidence in providing interpretation of direct-to-consumer genetic tests (66%) and communicating about legal protections of genetic information (65%). Respondents who frequently order tests are more likely to already participate in genetics CME (55%) than those who order infrequently (19%). Across the board, respondents would feel more comfortable integrating genetics/genomics into their practice with additional training, whether they order tests frequently (87%) or not (76%). The leading topics of interest included information about genetic testing options and communication of results, direct-to-consumer (DTC) testing, human genetics fundamentals, and ethical issues. Conclusions: Lack of specific knowledge impedes clinicians from incorporating genetics/genomics into practice and teaching, Experience with genetics (e.g., ordering genetic tests) is associated with increased confidence with performing genetics-related clinical activities. The vast majority of clinicians desire more training, regardless of their current use of genetic testing or referrals. Additional education is essential to increase the number of genomically literate clinicians and educators, thereby increasing patient access to genomic medicine. Next steps include working with clinical departments to develop general and specialty-specific educational materials for clinicians and trainees. From its earliest days, the field of human genetics has had a complex, and at times troubling, connection with racist ideologies. Although the modern field of human genetics and genomics has come a long way from those earlier errors, systemic racism remains engrained in its institutions and practices. Although a variety of efforts are needed to

Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature

Views of primary care providers on testing patients for genetic risks for common chronic diseases

Perceptions of personalized medicine in an academic health system: Educational findings